Pancreatic ductal adenocarcinoma is anticipated to be the second leading explanation for cancer death in america by 2030, in line with the National Institutes of Health (NIH). The International Cancer of the Pancreas Screening (CAPS) Consortium, the American Society for Gastrointestinal Endoscopy, and the National Comprehensive Cancer Network currently recommend surveillance of high-risk individuals, including […]
